However, the other DNA alterations did not contribute to stratification of patients into two prognostic risk groups (CIN and CIMP, Supplementary Figure S5D and S5G; p53 and BRAF, Supplementary Figure S6D and S6G). This evidence concerns the gene TP53 and cervical squamous intraepithelial neoplasia.